ReNeuron Successfully Automates Its Stem Cell Manufacturing Process on The Automation Partnership's CompacT SelecT …
CAMBRIDGE, England—-ReNeuron, a leading UK-based stem cell company, today announced the publication of a paper in the journal Biotechnology Letters demonstrating successful automation of the manufacturing of its ReN001 neural stem cell line for stroke in TAP’s CompacT SelecT™ automated cell culture system.
[Read the full article here]Related News:
ReNeuron Successfully Automates Its Stem Cell Manufacturing Process on …
ReNeuron inks stem cell manufacturing pact with Angel Biotech
ReNeuron gives update on progress of stroke stem cell clinical trial